NeuroPace Inc patients see 62 percent median seizure reduction at six months in largest FDA-reviewed study

Traders Union
All News
Companies
NeuroPace Inc reports seizure drop

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Market Voices

Companies

Ivan Andriyenko

28.06.2026

NeuroPace Inc patients see 62 percent median seizure reduction at six months in largest FDA-reviewed study — NeuroPace Inc reports seizure drop

Patients with drug-resistant focal epilepsy experienced a median 62 percent reduction in seizures by six months using the NeuroPace Inc RNS System, according to results from the largest FDA-reviewed prospective study in the history of neuromodulation.

This finding suggests significant potential for the RNS System as a treatment option for patients who do not respond to medication. The study represents a pivotal advancement in epilepsy care, pointing to new opportunities for those affected by this challenging condition.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

NeuroPace recently hosted a packed symposium focused on responsive thalamic neuromodulation for drug-resistant epilepsy at ASSFN2026, drawing strong interest from clinicians and researchers (article). In earlier findings, patients indicated a preference for the RNS System over VNS, citing more targeted and immediate seizure control (article). These developments have positioned the RNS System as a growing choice in advanced epilepsy care.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

By Mikhail Vnuchkov
21 hours ago

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

Editors' Picks

SpaceX falls out of orbit: Does anyone still want Musk’s stock?

By Oleg Tkachenko
Yesterday

SpaceX falls out of orbit: Does anyone still want Musk’s stock?

Editors' Picks

By Eugene Komchuk
08.07.2026

The crypto IPO problem: How high-profile listings became investor traps

Editors' Picks

All Editors' Top Picks

Latest NeuroPace News

NeuroPace Inc offers free webinar on RNS System for epilepsy patients

By Artem Shendetskii
Yesterday

NeuroPace Inc offers free webinar on RNS System for epilepsy patients

Companies

DHR Health pioneers responsive neurostimulation therapy with NeuroPace Inc RNS System in Texas

By Parshwa Turakhiya
07.07.2026

DHR Health pioneers responsive neurostimulation therapy with NeuroPace Inc RNS System in Texas

Companies

NeuroPace Inc RNS System gains favor for targeted seizure interruption

By Ashutosh Sureka
15.06.2026

NeuroPace Inc RNS System gains favor for targeted seizure interruption

Companies

All NeuroPace News

Mikhail Vnuchkov
21 hours ago

SK Hynix debuts on Nasdaq: Largest U.S. offering by foreign company

Oleg Tkachenko
Yesterday

SpaceX falls out of orbit: Does anyone still want Musk’s stock?

Eugene Komchuk
08.07.2026

The crypto IPO problem: How high-profile listings became investor traps

Anastasiia Chabaniuk
07.07.2026

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

Mikhail Vnuchkov
06.07.2026

Aiming for leadership: Payment giants prepare a new stablecoin

Daria Chernytska
58 min ago

Stephan Livera: BIP-110 enforces Luke Dashjr’s definitions on blockchain data

Elena Nikulina
1 hour ago

Mario Nawfal: South Korea exports over $100 billion in a month on AI demand

Olga Shendetskaya
2 hours ago

Japan does not face an external debt issue, Brad Setser argues

Yaroslav Dmytrenko
2 hours ago

Clarity Act is as vital as web legislation for U.S. economy, Joseph Lubin notes

Hanna Syniavska
2 hours ago

Shift to equity fundraising over tokens gains traction, Laura Shin notes

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Eugene Komchuk
16 hours ago

Circle wins approval to establish U.S. national trust bank

Circle wins approval to establish U.S. national trust bank

Ivan Andriyenko
17 hours ago

Oil market keeps risk premium as Hormuz traffic stalls

Oil market keeps risk premium as Hormuz traffic stalls

Igor Krasulya
19 hours ago

UAE oil output hits record high as Abu Dhabi pushes beyond OPEC limits

UAE oil output hits record high as Abu Dhabi pushes beyond OPEC limits

Eugene Komchuk
20 hours ago

Crypto market posts third consecutive quarterly loss

Crypto market posts third consecutive quarterly loss

Andrey Mastykin
20 hours ago

Nasdaq futures slip before SK Hynix U.S. debut

Nasdaq futures slip before SK Hynix U.S. debut

Top 5 companies for you

United States

Live News

Anton Kharitonov
Now

Microsoft stabilizes as AI strategy remains in focus

Anton Kharitonov
Now

Apple extends rally as AI strategy strengthens investor confidence

Anton Kharitonov
Now

Google rebounds as AI momentum supports investor confidence

Mykhailo Ihnatenko
Now

Intel stock faces rising volatility ahead of earnings season

Anton Kharitonov
Now

Bitcoin climbs toward resistance as ETF demand improves

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.